These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24655921)

  • 1. New hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapy.
    Lenjisa JL; Woldu MA; Satessa GD
    J Nanobiotechnology; 2014 Mar; 12():9. PubMed ID: 24655921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.
    Sosnik A; Chiappetta DA; Carcaboso AM
    J Control Release; 2009 Aug; 138(1):2-15. PubMed ID: 19445981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage targeted nanocarrier delivery systems in HIV therapeutics.
    Khan T; Mayuresh Patkar M; Momin M; Omri A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):903-918. PubMed ID: 32347124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicines for HIV therapy.
    Siccardi M; Martin P; McDonald TO; Liptrott NJ; Giardiello M; Rannard S; Owen A
    Ther Deliv; 2013 Feb; 4(2):153-6. PubMed ID: 23343155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting strategies for delivery of anti-HIV drugs.
    Ramana LN; Anand AR; Sethuraman S; Krishnan UM
    J Control Release; 2014 Oct; 192():271-83. PubMed ID: 25119469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
    Date AA; Destache CJ
    Biomaterials; 2013 Aug; 34(26):6202-28. PubMed ID: 23726227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in antiretroviral drug delivery using nanotechnology.
    Mallipeddi R; Rohan LC
    Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in nano-enabled therapeutics for neuroHIV management.
    Kaushik A; Jayant RD; Nair M
    Int J Nanomedicine; 2016; 11():4317-25. PubMed ID: 27621624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of polymeric nanoparticles in AIDS treatment and prevention.
    Khalil NM; Carraro E; Cótica LF; Mainardes RM
    Expert Opin Drug Deliv; 2011 Jan; 8(1):95-112. PubMed ID: 21143001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).
    Saravanan M; Asmalash T; Gebrekidan A; Gebreegziabiher D; Araya T; Hilekiros H; Barabadi H; Ramanathan K
    Pharm Nanotechnol; 2018; 6(1):17-27. PubMed ID: 29424324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting slow effective release antiretroviral therapy.
    Edagwa B; McMillan J; Sillman B; Gendelman HE
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1281-1291. PubMed ID: 28128004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards nanomedicines for neuroAIDS.
    Sagar V; Pilakka-Kanthikeel S; Pottathil R; Saxena SK; Nair M
    Rev Med Virol; 2014 Mar; 24(2):103-24. PubMed ID: 24395761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target Molecules and Delivery Vehicles for Anti-HIV Drugs In vitro and In vivo.
    Bolhassani A
    Curr Pharm Des; 2018; 24(29):3393-3401. PubMed ID: 29886823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel liquid formulation developed to deliver nanomedicine treatment for HIV/AIDS.
    Nanomedicine (Lond); 2010 Jul; 5(5):684. PubMed ID: 20662639
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
    Gao Y; Kraft JC; Yu D; Ho RJY
    Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
    Wong HL; Chattopadhyay N; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
    Gupta S; Kesarla R; Omri A
    Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.
    Vyas TK; Shah L; Amiji MM
    Expert Opin Drug Deliv; 2006 Sep; 3(5):613-28. PubMed ID: 16948557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.